Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yousryeia Abdel Rahman"'
Autor:
Yousryeia Abdel Rahman, Lobna Abdel wahid Ahmed, Rania Mohamed mahmoud Hafez, Rasha Mohamed Mahmoud Ahmed
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 31, Iss 3, Pp 332-342 (2019)
Background Helicobacter pylori causes several gastric, intestinal, and extraintestinal manifestations. It also causes persistent infection and can cause serious various hematological effects. Aims To investigate the hematological effect of H. pylori
Externí odkaz:
https://doaj.org/article/884f3ca3aaf3429d93a97c62d7253bf6
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 31, Iss 3, Pp 332-342 (2019)
Background Helicobacter pylori causes several gastric, intestinal, and extraintestinal manifestations. It also causes persistent infection and can cause serious various hematological effects. Aims To investigate the hematological effect of H. pylori
Autor:
Usama El-Safy, M. Akif Yesilipek, Yousryeia Abdel Rahman, Zakaria Al Hawsawi, Youssef Al-Tonbary, Ghazi Al Damanhouri, Shebl Said Shebl, Fernando Tricta, Yurdanur Kilinç, Mostafa A.S Salama, Zeynep Karakas, Mohamad H. Qari, Mohamed M. Badr, M Elalfy, Anne Stilman, Dilek Yazman, Noemi Toiber Temin, Yasser Wali
Publikováno v:
Pediatric Blood & Cancer. 61:879-884
Background A risk associated with the iron chelator deferiprone is the development of neutropenia or agranulocytosis. Accordingly, the product label recommends weekly blood monitoring and immediate interruption of treatment upon detection of an absol
Autor:
Mohssen, Elalfy, Yasser A, Wali, Mohamad, Qari, Ghazi, Al Damanhouri, Youssef, Al-Tonbary, Dilek, Yazman, Zakaria, Al Hawsawi, Zeynep, Karakas, Yurdanur, Kilinc, M Akif, Yesilipek, Mohamed, Badr, Usama, Elsafy, Mostafa, Salama, Yousryeia, Abdel Rahman, Shebl, Shebl, Anne, Stilman, Noemi, Toiber Temin, Fernando, Tricta
Publikováno v:
Pediatric bloodcancer. 61(5)
A risk associated with the iron chelator deferiprone is the development of neutropenia or agranulocytosis. Accordingly, the product label recommends weekly blood monitoring and immediate interruption of treatment upon detection of an absolute neutrop
Autor:
Zeynep Karakas, Yasser Wali, Shebl Said Shebl, M. Akif Yesilipek, Mohamad H. Qari, Fernando Tricta, Ghazi Abdullah Al Damnhouri, Mostafa A.S Salama, Dilek Yazman, Yurdanur Kilinç, M. A. Badr, Yousryeia Abdel Rahman, Zakaria Al Hawsawi, Youssef Al-Tonbary, Mohsen Saleh Elalfy, Usama El-Safy
Publikováno v:
Blood. 120:996-996
Abstract 996 The incidence of agranulocytosis during deferiprone (Ferriprox®) use has been reported in clinical trials where patients' neutrophil counts were generally monitored weekly and deferiprone was discontinued at the first sign of neutropeni